Journals / Fırat Tıp Dergisi / 2018 / Cilt: 23 - Sayı: 0

Obesity and Cancer

Obezite ve Kanser

Pages
61–67
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

If efforts in order to prevent obesity increase, the incidence of cancer will be reduced with the provision of weight control.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Obesity triggers many health problems, especially diabetes and atherosclerosis, or complicates treatment of these diseases.
📊
Key Findings & Data:Increased body weight and body fat ratio are characterized by endocrine, metabolic and immunological changes and are associated with many chronic diseases.
💡
Conclusion & Impact:If efforts in order to prevent obesity increase, the incidence of cancer will be reduced with the provision of weight control.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Obesity triggers many health problems, especially diabetes and atherosclerosis, or complicates treatment of these diseases. Increased body weight and body fat ratio are characterized by endocrine, metabolic and immunological changes and are associated with many chronic diseases. Various types of cancer are also associated with these diseases. The association of obesity with cancer is less known than with diabetes and cardiovascular effects. However, scientific data supports that increase of fat rate in the body may increase the incidence or cancer-related mortality rates in some types of cancer. These cancer types include colon, esophagus, gastric cardia, rectum, gall bladder, pancreas, kidney, over, endometrium, and postmenopausal breast cancers. In the literature, it has been shown that every 5 kg/m2 increase in body mass index leads to a 30% increase in any causal mortality and 10% increase in mortality due to cancer. For this reason, the protection of healthy body weight plays an important role especially in the prevention of these cancer types. If efforts in order to prevent obesity increase, the incidence of cancer will be reduced with the provision of weight control.

Özet

Obezite, diyabet ve ateroskleroz başta olmak üzere birçok sağlık sorununu tetiklemekte veya bu hastalıkların tedavisini güçleştirmektedir. Vücut ağırlığı ve vücut yağ oranının artması, endokrin, metabolik ve immünolojik değişikliklerle karakterize olup, çok sayıda kronik hastalıkla ilişkilidir. Çeşitli kanser türleri de bu hastalıklardandır. Obezitenin, diyabet ve kardiyovasküler etkilerine kıyasla kanser ile olan ilişkisi daha az bilinmektedir. Fakat bilimsel veriler vücut yağ oranı artışının bazı kanser türlerinde insidansı ya da kansere bağlı ölüm oranlarını arttırdığını desteklemektedir. Bu kanser türleri arasında kolon, özafagus, mide kardiya, rektum, safra kesesi, pankreas, böbrek, over, endometriyum ve postmenapozal meme kanserleri yer almaktadır. Literatürdeki verilerde vücut kitle indeksinin her 5 kg/m2 artışıyla herhangi bir nedenli mortalitede %30 ve kanser nedeniyle ölümde %10 artış olduğu gösterilmiştir. Bu nedenle özellikle bu kanser türlerinin önlenmesi çalışmalarında sağlıklı vücut kilosunu korunması önemli yer tutmaktadır. Obeziteyi önlemeye yönelik çabalar arttığında, kilo kontrolünün sağlanması ile kanser sıklığında da azalma yaşanacaktır.

🔖

Cite This Article

YILDIRIM, N. (2018). Obesity and Cancer. Fırat Tıp Dergisi, Cilt: 23 - Sayı: 0, 61–67. https://ajindex.com/articles/164914

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. TÜİK “Haber Bültenleri, Ölüm nedeni istatistik-ler. http://www.tuik.gov.tr/ 12.06.2015. Kanser daire başkanlığı. Türkiye kanser istatis-tikleri. http://kanser.gov.tr/ 12.06.2015.
  2. Wolin KY, Carson K, Coldits GA. Obesity and cancer. Oncologist 2010; 15: 556-65. American Cancer Society. Cancer Facts & Figu-res. American Cancer Society, 2014. TÜBA-Gıda, beslenme ve kanserin önlenmesi sempozyumu raporu. 23.05.2015.
  3. Vainio H, Bianchini F, editors. IARC Handbo-oks of Cancer Prevent–Weight Control and Physical Activity. Lyon, France: IARC Press; 2002.
  4. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-38.
  5. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systema-tic review and meta-analysis of prospective ob-servational studies. Lancet 2008; 371: 569-78.
  6. Basen K, Chang M. Obesity and cancer risk: recent review and evidence. Curr Oncol Rep 2011; 13: 71-6.
  7. Hursting SD, Digiovanni J, Dannenberg AJ, et al. Obesity, energy balance, and cancer: New opportunities for prevention. Cancer Prev Res (Phila) 2012; 5: 1260-72.
  8. Nimri L, Saadi J, Peri I, et al. Mechanisms lin-king obesity to altered metabolism in mice co-lon carcinogenesis. Oncotarget 2015; 6: 38195-209.
  9. Saxena NK, Vertino PM, Anania FA, et al. Leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J Biol Chem 2007; 282: 13316-25.
  10. Fazolini NP, Cruz AL, Werneck MB, et al. Leptin activation of mTOR pathway in intesti-nal epithelial cell triggers lipid droplet forma-tion, cytokine production and increased cell pro-liferation. Cell Cycle 2015; 14: 2667-76. Ghosh S,Ashcraft K. An IL-6 link between obesity and cancer. Front Biosci 2013; 5: 461-78.
  11. Grossmann ME, Nkhata KJ, Mizuno NK, et al. Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 2008; 98: 370-9.
  12. Hopkins BD, Goncalves MD, Cantley LC. Obe-sity and cancer mechanisms: cancer metabo-lism. J Clin Oncol 2016; 34: 4277-83.
  13. Housa D, Housová J, Vernerová Z, et al. Adi-pocytokines and cancer. Physiol Res 2006; 55: 233-44.
  14. Osborn O, Olefsky JM. The cellular and signa-ling networks linking the immune system and metabolism in disease. Nat Med 2012; 18: 363-74.
  15. Chen W, Wang S, Tian T, et al. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and c